Smoking-Associated Carcinogen-Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Smoking is a major cause of lung cancer, but the precise molecular mechanisms linking carcinogens to cancer development remain unclear.
• Key cigarette smoke carcinogens, such as NNK and BaP, require further investigation in models simulating prolonged inhalation exposure.

Purpose of the Study:

• To elucidate the molecular pathways connecting smoking-associated carcinogens to inflammation and oncogenic transformation in lung cancer.
• To investigate the role of IL-1 receptor-associated kinase-4 (IRAK4) in carcinogen-induced lung tumorigenesis.

Main Methods:

• Prolonged intratracheal administration of NNK and BaP to mouse models.
• Analysis of IL-1 receptor-associated kinase-4 (IRAK4) expression in murine lung tissues and human lung cancer samples.
• Evaluation of IRAK4 inhibition effects on lung cancer cell lines and xenografts.

Main Results:

• Carcinogen-exposed mice showed increased lung cancer rates, myeloid inflammation, and elevated IL-1β in macrophages.
• IRAK4 was overexpressed in carcinogen-exposed murine lungs and human lung cancers.
• IRAK4 inhibition reduced lung cancer cell invasion and xenograft growth, impacting microtubule-associated proteins.

Conclusions:

• Smoking-associated carcinogens drive oncogenic transformation through inflammatory IRAK4 activation.
• IRAK4 represents a critical link between smoking-induced inflammation and lung cancer development.
• Targeting IRAK4 may offer a novel therapeutic strategy for smoking-related lung cancers.